de Lázaro, I., Cossu, G., & Kostarelos, K. (2017). Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming. EMBO Mol Med.
Chicago Style Citationde Lázaro, Irene, Giulio Cossu, and Kostas Kostarelos. "Transient Transcription Factor (OSKM) Expression Is Key Towards Clinical Translation of In vivo Cell Reprogramming." EMBO Mol Med 2017.
MLA Citationde Lázaro, Irene, Giulio Cossu, and Kostas Kostarelos. "Transient Transcription Factor (OSKM) Expression Is Key Towards Clinical Translation of In vivo Cell Reprogramming." EMBO Mol Med 2017.
Warning: These citations may not always be 100% accurate.